You are here: Home About Us Non-Executive Board

Non-Executive Board Members and Observers

Iain Ferguson: Chairman

Iain combines an original science and research background with success in new product commercialization. He has substantial listed company leadership experience, an interest in new technology venture businesses and has a broad Chair and Non-Executive background, including FTSE 100 & FTSE 250 companies.  Iain spent over 25 years at Unilever and his roles including Vice President Corporate Development and Chairman of Unilever Ventures.  He was CEO of Tate & Lyle plc from 2003-2009 where he transformed a bulk sugar business into a global provider of speciality ingredients to the food and beverage industries and is currently Chairman of Berendsen plc and the Stobart Group. He is also the lead Non-Executive Director for the Department for Environment, Food & Rural Affairs (Defra), where he has significant involvement with the Government in establishing the departmental strategy.

 

Kevin D’Silva: Non-Executive Director

Kevin’s career has been in the life science products and the medical devices industries where he has been CEO and Chairman of a number of private and publically quoted companies. He has jointly founded 2 companies: Warne Surgical which was sold to Teleflex Inc and a publicly listed business which now trades as Bioquell plc. He is currently Chairman of AI2 Ltd (private), Imorphics Ltd (private), Crystallon Ltd and Oxford Cryosystems Ltd (private), Monica Healthcare Ltd (private), and is a Director of Surface Transforms plc (public). Through his consultancy partnership, Salusinvest LP, he is a board member of Metrasens Ltd (private) and Michelson Diagnostics Ltd (private) and advises a number of EU and US listed companies. He is a chemical engineer from Leeds University and has an MBA from Manchester Business School. See: www.salusinvest.com

 

Douglas Hutchison: Non-Executive Director

Douglas qualified as a veterinary surgeon in 1980, and after three years in general practice, he worked in the pharmaceutical and biotechnology industries within increasing leadership roles, ultimately as CEO of a biotechnology company based in Cambridge. In 1990, he founded Veterinary Business Development which grew to be one of the largest communications companies in the veterinary sector worldwide.  This published market-leading titles such as Veterinary Times and The Veterinary Business Journal and was sold successfully to the global corporation, Wolters Kluwer, in 2000. Since that time, he has invested in a number of early stage companies in a variety of sectors and acts as a non-executive director in some.  He is Chairman of BioMedical Business Partners, Biogelx, and Virtual Recall.  He is a former director of the British Veterinary Association; and former trustee of VETAID.  He was recruited as a Partner in the global executive search firm, Odgers Berndtson, in 2005.